Milan Chheda, MD

Medical Oncologist, Neuro-Oncologist

Milan Chheda

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Video thumbnail for Milan Chheda, MD

Watch video on YouTube

Milan Chheda, MD

4 mins

Washington University neuro-oncologist Milan Chheda, MD, discusses what brain tumor patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Chheda: https://siteman.wustl.edu/doctor/chheda-milan/

Explore the Brain Tumor Center at Siteman: https://siteman.wustl.edu/treatment/cancer-types/brain-tumor-center/

Learn more about how Siteman personalizes brain tumor treatment: https://siteman.wustl.edu/personalized-brain-tumor-treatment/

Learn more about how Siteman's innovations in brain tumor surgery are advancing treatment: https://siteman.wustl.edu/innovations-brain-tumor-surgery/

Clinical Expertise

  • Brain Tumors

Primary Academic Title

Professor of Medicine, Division of Medical Oncology, Director of Neuro-Oncology, WashU Medicine; Associate Director of The Brain Tumor Center at Siteman

Board Certification

  • 2008: American Board of Psychiatry and Neurology
  • 2015: United Council for Neurologic Subspecialties, Neuro-Oncology

Training

  • 2001 - 2002: Intern, Internal Medicine, Yale - New Haven Hospital, New Haven, CT
  • 2002 - 2005: Resident, Neurology, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, MA
  • 2005 - 2007: Fellow, Neuro-Oncology, Massachusetts General Hospital and Dana-Farber Cancer Institute, Boston, MA
  • 2006 - 2015: Postdoctoral Fellow, Dana-Farber Cancer Institute, Boston, MA; and Broad Institute, Cambridge, MA
  • 2010 - 2015: Postdoctoral Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY

Education

  • 2001: MD, Albert Einstein College of Medicine, New York, NY

Research & Selected Publications

Research Interest

I have a particular research interest in identifying the genes that drive tumor-initiating cells, sometimes known as cancer stem cells, in order to discover new ways to treat adult and pediatric brain tumors.

 

Research Publications

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Authors:

Garfinkle EAR, Perales-Linares R, Gimple RC, one or more additional authors omitted Chheda MG, one or more additional authors omitted Johanns TM

Journal & Year:

Nat Cancer | 2026

Oncolytic zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses
Authors:

Cashman KS, Mistry AM, Kesarwani A, one or more additional authors omitted Chheda MG, Nair S

Journal & Year:

Neuro-oncology | 2026

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial
Authors:

Campian JL, Le SB, Ghiaseddin A, one or more additional authors omitted Chheda MG, one or more additional authors omitted Tran DD

Journal & Year:

Nat Commun | 2026

Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma
Authors:

Li YD, Giles DA, Huang Y, one or more additional authors omitted Chheda MG

Journal & Year:

Nat Commun | 2026

Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapy
Authors:

Hirsch AJ, de Andrade Costa A, German C, one or more additional authors omitted Chheda MG

Journal & Year:

Cell Rep Med | 2025

Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Authors:

Iglesia MD, Jayasinghe RG, Chen S, one or more additional authors omitted Chheda MG, one or more additional authors omitted Ding L

Journal & Year:

Nat Cancer | 2024

A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma
Authors:

Huang J, Campian JL, DeWees TA, one or more additional authors omitted Chheda MG

Journal & Year:

Int J Radiat Oncol Biol Phys | 2024

Tumour evolution and microenvironment interactions in 2D and 3D space
Authors:

Mo CK, Liu J, Chen S, one or more additional authors omitted Chheda MG, one or more additional authors omitted Ding L

Journal & Year:

Nature | 2024